| Financial Year |
March 31 2020 |
| Monetary Funds |
83,931,958.84 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
554,411.79 |
| Accounts Receivable |
837,017,095.61 |
| Advances to Suppliers |
128,164,170.75 |
| Other Receivables |
2,190,975,382.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
674,631,577.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
184,900,808.65 |
| Total Current Assets |
4,138,551,975.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
111,372,475.68 |
| Investment Properties |
-- |
| Fixed Assetes |
625,729,021.65 |
| Under-construction Projects |
355,587,471.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,534,319,493.23 |
| R&D expenses |
917,534.44 |
| Goodwill |
1,508,253.14 |
| Long-Term Deferred and Prepaid Expenses |
3,956,432.40 |
| Deferred Income Tax Assets |
26,543,662.08 |
| Other Non-Current Assets |
314,205,181.07 |
| Sub-Total of Non-Current Assets |
4,237,346,004.50 |
| Total Assets |
8,375,897,979.76 |
| Short-Term Loans |
1,390,694,628.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
562,115,478.70 |
| Accounts Received In Advance |
255,861,385.32 |
| Employee Compensation Payable |
50,859,496.17 |
| Taxes Payable |
65,693,047.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,525,455,752.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,741,188,646.66 |
| Other Current Liabilities |
200,000,000.00 |
| Sub-Total of Current Liabilities |
7,833,155,611.70 |
| Long-term Loans |
768,907,863.38 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
597,460,040.11 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,580,679,273.58 |
| Deferred Income Tax Liabilities |
-52,959,217.50 |
| Other Non-Current Liabilities |
170,640,549.62 |
| Sub-Total of Non-Current Liabilities |
4,235,024,231.40 |
| Total Liabilities |
12,068,179,843.10 |
| Paid-In Capital(Or Share Stock) |
1,319,952,922.00 |
| Capital Surplus |
2,191,772,620.12 |
| Surplus Reserve |
106,646,366.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-6,986,895,932.38 |
| Minority Stockholder's Interest |
5,460,296.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-3,697,742,160.01 |
| Owner's Equity（Stockholder's Equity） |
-3,692,281,863.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,375,897,979.76 |
